Back
Direxion Daily S&P Biotech Bull 3X ETF Vs. ProShares Ultra Financials Industry Stock Comparison
Sell
44
LABU
Direxion Daily S&P Biotech Bull 3X ETF
Last Price:
127.00
Seasonality Move:
18.53%
Buy
87
UYG
ProShares Ultra Financials
Last Price:
96.37
Seasonality Move:
5.48%
Sell
44
Direxion Daily S&P Biotech Bull 3X ETF (LABU)
is a Sell
Is Direxion Daily S&P Biotech Bull 3X ETF a Buy, Sell or Hold?
- The current Direxion Daily S&P Biotech Bull 3X ETF [LABU] share price is $126.80. The Score for LABU is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- LABU is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
ProShares Ultra Financials (UYG)
is a Buy
Is ProShares Ultra Financials a Buy, Sell or Hold?
- The current ProShares Ultra Financials [UYG] share price is $96.48. The Score for UYG is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
- UYG is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
LABU Stock Price Chart
What is Direxion Daily S&P Biotech Bull 3X ETF's stock price today?
-
The Direxion Daily S&P Biotech Bull 3X ETF share price today is $126.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LABU is experiencing buying pressure, which is a positive indicator for future bullish movement.
UYG Stock Price Chart
What is ProShares Ultra Financials's stock price today?
-
The ProShares Ultra Financials share price today is $96.48
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UYG is experiencing selling pressure, which indicates risk of future bearish movement.
LABU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.87 | Sell |
Relative Strength Index (14 RSI): | 54.46 | Buy |
Chaikin Money Flow: | 585685 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (110.03 - 135.93) | Buy |
Bollinger Bands (100): | (118.28 - 139.08) | Sell |
UYG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.66 | Buy |
Relative Strength Index (14 RSI): | 73.19 | Buy |
Chaikin Money Flow: | -45499 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (82.42 - 93.62) | Buy |
Bollinger Bands (100): | (69.31 - 85.29) | Buy |
LABU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 112.06 | Buy |
20-day SMA: | 122.86 | Buy |
50-day SMA: | 124.83 | Buy |
200-day SMA: | 123.22 | Buy |
8-day EMA: | 118.01 | Buy |
20-day EMA: | 120.09 | Buy |
50-day EMA: | 123.73 | Buy |
200-day EMA: | 122.39 | Buy |
UYG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 93.44 | Buy |
20-day SMA: | 89.56 | Buy |
50-day SMA: | 83.31 | Buy |
200-day SMA: | 70.76 | Buy |
8-day EMA: | 93.93 | Buy |
20-day EMA: | 90.4 | Buy |
50-day EMA: | 84.69 | Buy |
200-day EMA: | 71.91 | Buy |
Direxion Daily S&P Biotech Bull 3X ETF Earnings Growth & LABU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Financials Earnings Growth & UYG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Direxion Daily S&P Biotech Bull 3X ETF Technical Analysis
Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ProShares Ultra Financials Technical Analysis
Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |